Gemcitabine and white blood cell count decreased Patient Reports February 11, 2012

Gemcitabine Side Effects Report #4565182-X
Gemcitabine side effect was reported by a Health Professional from on Jan 27, 2005. Female patient, 57 years of age, weighting 120.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: neutrophil count decreased, white blood cell count decreased. Gemcitabine dosage: 1000 MG/M2 IV Q 14 DAYS. During the same period patient was treated with OXALIPLATIN. Patient recovered.

Gemcitabine Side Effects Report #4629033-7
Gemcitabine side effect was reported by a Health Professional from on Apr 05, 2005. Female patient, 57 years of age, weighting 120.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: neutrophil count decreased, white blood cell count decreased. Gemcitabine dosage: 1000MG/M2 I.V., Q 14 DAYS. During the same period patient was treated with OXALIPLATIN. Patient recovered.

Gemcitabine Side Effects Report #4667704-7
Gemcitabine side effect was reported by a Health Professional from on May 19, 2005. Male patient, weighting 160.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: febrile neutropenia, infection , white blood cell count decreased. Gemcitabine dosage: 1000MG/M2 DAY 1 + 15 INTRAVENOU. During the same period patient was treated with CISPLATIN, LISINOPRIL, COUMADIN, FERROUS GLUCONATE, ARANESP, NEULASTA, OXYCONTIN, VICODIN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4646662-5
Gemcitabine side effect was reported by a Health Professional from on Apr 22, 2005. Female patient, 47 years of age, weighting 116.0 lb, was diagnosed with ovarian cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Gemcitabine dosage: 1000MG/M2 D1 + 8. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.


Gemcitabine Side Effects Report #4655819-9
Gemcitabine side effect was reported by a Health Professional from on May 06, 2005. Female patient, 47 years of age, weighting 116.0 lb, was diagnosed with ovarian cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Gemcitabine dosage: 1000 MG/M2 D1 + 8. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4869735-0
Gemcitabine side effect was reported by a Physician from UNITED STATES on Dec 08, 2005. Male patient, 82 years of age, weighting 125.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, infection , pneumonia , white blood cell count decreased. Gemcitabine dosage: 1250 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with COUMADIN, ATENOLOL, NORVASC, LIPITOR, VITAMINS, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4564602-4
Gemcitabine side effect was reported by a Physician from on Jan 13, 2005. Female patient, 58 years of age, weighting 134.5 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dyspnoea, platelet count increased, pleural effusion, pneumonia , pyrexia, swelling, tenderness, white blood cell count decreased. Gemcitabine dosage: 1000 MG/M2. During the same period patient was treated with KETOPROFEN, LEDERSCON. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #6128219-2
Gemcitabine side effect was reported by a Physician from HUNGARY on Mar 10, 2009. Female patient, 59 years of age, weighting 114.6 lb, was diagnosed with metastatic squamous cell carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: platelet count increased, skin reaction, urticaria, white blood cell count decreased. Gemcitabine dosage: 1800 MG, OTHER. During the same period patient was treated with PENTOXIFYLLINE, CARBOPLATIN. Patient recovered.

Gemcitabine Side Effects Report #4928133-1
Gemcitabine side effect was reported by a Physician from GERMANY on Feb 14, 2006. Male patient, 57 years of age, was diagnosed with mantle cell lymphoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count decreased, pneumonia , red blood cell count decreased, white blood cell count decreased. Gemcitabine dosage: 2100 MG 1X PER 1 WK INTRAVENOUS. Patient was hospitalized. Patient recovered.


Gemcitabine Side Effects Report #4994338-7
Gemcitabine side effect was reported by a Health Professional from TURKEY on Apr 14, 2006. Male patient, 52 years of age, weighting 147.7 lb, was diagnosed with lung neoplasm malignant and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, sepsis , white blood cell count decreased. Gemcitabine dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 12/16/2005.

Gemcitabine Side Effects Report #4985611-7
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2006. Male patient, weighting 174.2 lb, was diagnosed with hodgkin's disease  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: neutrophil count decreased, white blood cell count decreased. Gemcitabine dosage: 153 MG. During the same period patient was treated with VINBLASTINE SULPHATE. Patient recovered.

Gemcitabine Side Effects Report #5771927-3
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on June 12, 2008. Male patient, 60 years of age, weighting 169.0 lb, was diagnosed with head and neck cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: blood creatine increased, haemoglobin decreased, white blood cell count decreased. Gemcitabine dosage: 1125 MG/M2 EVERY 14 DAYS IV. During the same period patient was treated with PEMETREXED, GABAPENTIN, MINOCYCLINE, LEXAPRO, SENNA, LIPITOR. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5727100-8
Gemcitabine side effect was reported by a Physician from JAPAN on Apr 23, 2008. Female patient, weighting 121.3 lb, was diagnosed with gallbladder cancer non-resectable, prophylaxis of nausea and vomiting and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: flushing, neutrophil count decreased, platelet count decreased, stomatitis, white blood cell count decreased. Gemcitabine dosage: 1200 MG, UNK. During the same period patient was treated with KYTRIL, DECADRON. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5803364-7
Gemcitabine side effect was reported by a Physician from JAPAN on June 24, 2008. Female patient, weighting 121.3 lb, was diagnosed with gallbladder cancer non-resectable, prophylaxis of nausea and vomiting and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: neutrophil count decreased, platelet count decreased, rash , stomatitis, white blood cell count decreased. Gemcitabine dosage: 1200 MG, UNK. During the same period patient was treated with KYTRIL, DECADRON. Patient was hospitalized. Patient recovered.


Gemcitabine Side Effects Report #4900817-0
Gemcitabine side effect was reported by a Physician from SWEDEN on Jan 10, 2006. Female patient, 61 years of age, weighting 163.1 lb, was diagnosed with breast cancer metastatic and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, epistaxis, fatigue, haemoglobin decreased, neutrophil count decreased, pyrexia, thrombocytopenia, white blood cell count decreased. Gemcitabine dosage: MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5088954-4
Gemcitabine side effect was reported by a Physician from UNITED KINGDOM on Aug 03, 2006. Female patient, 41 years of age, weighting 119.0 lb, was diagnosed with breast cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, c-reactive protein increased, pharyngolaryngeal pain, pyrexia, tonsillitis, white blood cell count decreased. Gemcitabine dosage: 3000 MG, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, ONDANSETRON, DEXAMETHASONE, RANITIDINE, CHLORPHENAMINE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4881660-8
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 11, 2006. Female patient, weighting 269.0 lb, was diagnosed with breast cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain , nausea , platelet count decreased, white blood cell count decreased. Gemcitabine dosage: unknown. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5873758-2
Gemcitabine side effect was reported by a Consumer or non-health professional from BELGIUM on Sept 04, 2008. Male patient, 64 years of age, weighting 178.6 lb, was diagnosed with bladder cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: anaemia, candidiasis, cardiac valve vegetation, endocarditis , platelet count decreased, staphylococcal infection , white blood cell count decreased. Gemcitabine dosage: 1000 MG/M**2 CYC. During the same period patient was treated with CISPLATIN, ASAFLOW, PERSANTINE RETARD, UNIDIAMICRON, LYRICA, MEDROL, SPIRALEXA, TEMESTA. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5064919-3
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on July 27, 2006. Female patient, weighting 142.6 lb, was diagnosed with angiosarcoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: neutrophil count decreased, white blood cell count decreased. Gemcitabine dosage: 800 MG/M2 D1, D8 IV. During the same period patient was treated with CAPECITABINE. Patient recovered.


Gemcitabine Side Effects Report #5122120-9
Gemcitabine side effect was reported by a Pharmacist from UNITED STATES on Oct 04, 2006. Male patient, 66 years of age, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dry skin, epistaxis, haematocrit decreased, haemoglobin decreased, international normalised ratio increased, platelet count decreased, swelling, white blood cell count decreased. Gemcitabine dosage: 2200MG IV. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5927994-7
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 22, 2008. Female patient, weighting 112.7 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Gemcitabine dosage: 618 MG. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.